Vivus.com

VIVUS. VIVUS is dedicated to addressing the therapeutic needs of patients with serious medical conditions and life-limiting diseases.

Today's Vivus.com headlines: Observe fresh posts and updates on VIVUS. This site’s feed is stale or rarely updated (or it might be broken for a reason), but you may check related news or Vivus.com popular pages instead. It is generally safe for browsing, so you may click any item to proceed to the site.

News, stories and media buzz related to VIVUS

Subscribe to related news

In brief: CQRC urges passage of bid-delay, Vertess closes three deals
via hmenews

11/18/2016 HME News Staff WASHINGTON – The Council for Quality Respiratory Care this week urged lawmakers to pass legislation that would delay steep cuts to reimbursement for home oxygen. The Patient Access to Durable Medical Equipment Act would reinstate...
Dan Strutton posted an update: nursing home, healthcare providers, allied healthwith only […]
via jivinjari

nursing home, healthcare providers, allied healthwith only two torpedoes. Then test it on your vision by dropping individual drop into your eye. You will feel a of a sting. Keep adding a torpedo up to the sting is not really that severe or so that it...
VIVUS Extends Return Date of STENDRA Commercial Rights
via sauditopbusiness

MOUNTAIN VIEW, CA—(Marketwired – August 29, 2016) – VIVUS, Inc. (NASDAQ: VVUS) (“VIVUS”) and Auxilium Pharmaceuticals, Inc., a subsidiary of Endo International plc (“Auxilium”), today announced an extension of the termination date of the license agreement...
Fat, Obesity & Weight Loss Western Academia’s Outlook Sponsored by Minister EnQi & the God Complex Course Studen...
via 40dayfruitfast

The Views Expressed here are not those of the Amber Institute Sports Clinics of America or Minister EnQi THE BEST WAY TO ATTACK FAT & ALL OF ITS FACES IS HERE CLICK THE LINK BELOW: KemiLuminescence FatBurner Plus Obesity: Determining The Cause...
Safeguard Scientifics Announces Fourth Quarter and Full-Year 2014 Financial Results
via vivalikes

Wayne, PA (PRWEB) March 05, 2015 Safeguard Scientifics, Inc. (NYSE:SFE) today announced fourth quarter and full-year 2014 financial results. For the three months ended December 31, 2014, Safeguard’s net loss was $ 15.1 million, or $ 0.73 per share,...

Vivus.com popular pages

VIVUS: Advancing Innovative Clinical Therapies

VIVUS is dedicated to addressing the therapeutic needs of patients with serious medical conditions and life-limiting diseases.
Medical Information: 1-888-998-4887

VIVUS, Inc. is a drug-development company dedicated to the development and commercialization of next-generation therapeutic products addressing obesity and sexual health.